Credit Agricole
NBIX icon

Credit Agricole’s Neurocrine Biosciences NBIX Stock Holding History

Credit Agricole’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.89M Buy
34,940
+26,149
+297% +$3.88M 0.01% 643
2026
Q1 		$1.16M Sell
8,791
-23
-0.3% -$3.05K ﹤0.01% 1032
2025
Q4 		$1.25M Buy
8,814
+1,203
+16% +$174K ﹤0.01% 985
2025
Q3 		$1.07M Buy
+7,611
New +$1.03M ﹤0.01% 930
2025
Q1 		$786K Sell
7,109
-438
-6% -$55.5K ﹤0.01% 965
2024
Q4 		$1.03M Buy
7,547
+947
+14% +$117K ﹤0.01% 916
2024
Q3 		$760K Sell
6,600
-7,006
-51% -$960K ﹤0.01% 860
2024
Q2 		$1.87M Buy
13,606
+6,400
+89% +$878K 0.01% 583
2024
Q1 		$955K Buy
+7,206
New +$984K 0.01% 569
2021
Q3 		– Sell
-500
Closed -$49K – 715
2021
Q2 		$49K Hold
500
– – ﹤0.01% 500
2021
Q1 		$49K Buy
+500
New +$52.4K ﹤0.01% 451
2017
Q4 		– Sell
-1,000
Closed -$61K – 826
2017
Q3 		$61K Hold
1,000
– – ﹤0.01% 1387
2017
Q2 		$46K Buy
+1,000
New +$48.5K ﹤0.01% 1387
2016
Q4 		– Sell
-2,792
Closed -$141K – 1526
2016
Q3 		$141K Buy
+2,792
New +$139K ﹤0.01% 1505

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Credit Agricole's NBIX Position: Q2 2026 in Review

Credit Agricole increased its Neurocrine Biosciences (NBIX) stake by 297% in Q2 2026, buying an estimated $3.88M and bringing the position to 34,940 shares worth $5.89M. The position accounts for 0.01% of the portfolio, ranked #643.

Credit Agricole first reported a position in NBIX in Q3 2016 and has held it in 14 quarters since. 771 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Credit Agricole held 34,940 shares of Neurocrine Biosciences worth $5.89M as of Q2 2026.
  • Credit Agricole bought 26,149 Neurocrine Biosciences shares in Q2 2026, an estimated $3.88M.
  • Neurocrine Biosciences made up 0.01% of Credit Agricole's portfolio in Q2 2026, its #643 holding.
  • Credit Agricole first reported a position in Neurocrine Biosciences in Q3 2016 and has held it in 14 quarters since.
  • 771 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.